Symbols / GOSS $0.35 -6.51% Gossamer Bio, Inc.

Healthcare • Biotechnology • United States • NMS
GOSS Chart
About

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 81.18M
Enterprise Value 152.81M Income -170.37M Sales 48.47M
Book/sh -0.53 Cash/sh 0.58 Dividend Yield —
Payout 0.00% Employees 161 IPO —
P/E — Forward P/E -1.83 PEG —
P/S 1.67 P/B -0.66 P/C —
EV/EBITDA -0.94 EV/Sales 3.15 Quick Ratio 2.36
Current Ratio 2.64 Debt/Eq — LT Debt/Eq —
EPS (ttm) -0.75 EPS next Y -0.19 EPS Growth —
Revenue Growth 47.10% Earnings 2026-05-14 ROA -41.86%
ROE — ROIC — Gross Margin 100.00%
Oper. Margin -3.34% Profit Margin 0.00% Shs Outstand 234.70M
Shs Float 211.16M Short Float 16.58% Short Ratio 1.14
Short Interest — 52W High 3.87 52W Low 0.32
Beta 2.16 Avg Volume 16.12M Volume 9.77M
Target Price $3.69 Recom Hold Prev Close $0.37
Price $0.35 Change -6.51%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$3.69
Mean price target
2. Current target
$0.35
Latest analyst target
3. DCF / Fair value
$-7.16
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.35
Low
$0.30
High
$15.00
Mean
$3.69

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-23 down Cantor Fitzgerald Overweight → Neutral —
2026-03-06 main HC Wainwright & Co. Buy → Buy $5
2026-03-05 main Oppenheimer Outperform → Outperform $3
2026-02-24 down Wedbush Outperform → Neutral $1
2026-02-24 down Barclays Overweight → Underweight $0
2026-02-24 down Leerink Partners Outperform → Market Perform $1
2026-01-28 init Barclays — → Overweight $9
2026-01-22 reit HC Wainwright & Co. Buy → Buy $10
2025-09-11 reit Cantor Fitzgerald Overweight → Overweight —
2025-09-10 up UBS Neutral → Buy $9
2025-08-06 main Wedbush Outperform → Outperform $5
2025-07-14 init Scotiabank — → Sector Outperform $11
2025-05-16 main Goldman Sachs Buy → Buy $8
2025-05-16 reit Wedbush Outperform → Outperform $4
2025-04-17 main Goldman Sachs Buy → Buy $7
2025-03-14 reit Wedbush Outperform → Outperform $4
2025-01-30 reit HC Wainwright & Co. Buy → Buy $10
2024-11-11 reit HC Wainwright & Co. Buy → Buy $10
2024-09-17 reit HC Wainwright & Co. Buy → Buy $10
2024-08-30 reit HC Wainwright & Co. Buy → Buy $10
News
RSS: Latest GOSS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-02 HASNAIN FAHEEM Chief Executive Officer — 280,000 $0.00 $0
2026-01-02 GIRAUDO BRYAN M. Chief Operating Officer — 115,750 $0.00 $0
2026-01-02 PETERSON CARYN Officer — 84,500 $0.00 $0
2026-01-02 ARANDA RICHARD Officer — 93,750 $0.00 $0
2026-01-02 CHRISTIAN WAAGE Officer — 84,500 $0.00 $0
2026-01-02 SMITH ROBERT PAUL JR Officer — 93,750 $0.00 $0
2025-10-01 HASNAIN FAHEEM Chief Executive Officer — 437,500 $0.00 $0
2025-10-01 GIRAUDO BRYAN M. Chief Operating Officer — 181,250 $0.00 $0
2025-10-01 PETERSON CARYN Officer — 125,000 $0.00 $0
2025-10-01 ARANDA RICHARD Officer — 162,500 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
48.47
-57.74%
114.70
0.00
0.00
Operating Revenue
48.47
-57.74%
114.70
0.00
0.00
Operating Expense
211.72
+21.25%
174.62
+0.50%
173.76
-20.49%
218.53
Research And Development
174.09
+25.71%
138.49
+2.35%
135.30
-20.84%
170.92
Selling General And Administration
37.63
+4.15%
36.13
-6.04%
38.45
-19.23%
47.61
General And Administrative Expense
37.63
+4.15%
36.13
-6.04%
38.45
-19.23%
47.61
Other Gand A
37.63
+4.15%
36.13
-6.04%
38.45
-19.23%
47.61
Total Expenses
211.72
+21.25%
174.62
+0.50%
173.76
-20.49%
218.53
Operating Income
-163.25
-172.46%
-59.92
+65.52%
-173.76
+20.49%
-218.53
Total Operating Income As Reported
-170.73
-184.93%
-59.92
+67.39%
-183.76
+15.94%
-218.59
EBITDA
-158.47
-296.49%
-39.97
+75.32%
-161.92
+23.29%
-211.07
Normalized EBITDA
-150.99
-277.79%
-39.97
+73.69%
-151.92
+28.00%
-211.00
Reconciled Depreciation
1.00
-75.86%
4.15
-5.34%
4.38
-0.99%
4.43
EBIT
-159.47
-261.46%
-44.12
+73.47%
-166.31
+22.83%
-215.50
Total Unusual Items
-7.47
0.00
+100.00%
-10.00
-15284.62%
-0.07
Total Unusual Items Excluding Goodwill
-7.47
0.00
+100.00%
-10.00
-15284.62%
-0.07
Special Income Charges
-7.47
0.00
+100.00%
-10.00
-15284.62%
-0.07
Other Special Charges
7.47
—
10.00
+15284.62%
0.07
Net Income
-170.37
-201.39%
-56.53
+68.56%
-179.82
+21.61%
-229.38
Pretax Income
-170.46
-206.39%
-55.63
+69.06%
-179.82
+21.61%
-229.38
Net Non Operating Interest Income Expense
-9.02
+7.38%
-9.74
+15.42%
-11.51
+6.37%
-12.30
Interest Expense Non Operating
10.99
-4.58%
11.52
-14.76%
13.51
-2.66%
13.88
Net Interest Income
-9.02
+7.38%
-9.74
+15.42%
-11.51
+6.37%
-12.30
Interest Expense
10.99
-4.58%
11.52
-14.76%
13.51
-2.66%
13.88
Interest Income Non Operating
1.97
+10.74%
1.78
-10.92%
2.00
+26.15%
1.58
Interest Income
1.97
+10.74%
1.78
-10.92%
2.00
+26.15%
1.58
Other Income Expense
1.81
-87.06%
14.02
+157.00%
5.46
+277.06%
1.45
Other Non Operating Income Expenses
9.29
-33.75%
14.02
-9.28%
15.46
+922.22%
1.51
Tax Provision
-0.09
-109.85%
0.89
0.00
0.00
Tax Rate For Calcs
0.00
-100.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-170.37
-201.39%
-56.53
+68.56%
-179.82
+21.61%
-229.38
Net Income From Continuing Operation Net Minority Interest
-170.37
-201.39%
-56.53
+68.56%
-179.82
+21.61%
-229.38
Net Income From Continuing And Discontinued Operation
-170.37
-201.39%
-56.53
+68.56%
-179.82
+21.61%
-229.38
Net Income Continuous Operations
-170.37
-201.39%
-56.53
+68.56%
-179.82
+21.61%
-229.38
Normalized Income
-162.90
-188.17%
-56.53
+66.71%
-169.82
+25.95%
-229.31
Net Income Common Stockholders
-170.37
-201.39%
-56.53
+68.56%
-179.82
+21.61%
-229.38
Diluted EPS
-0.75
-200.00%
-0.25
+78.81%
-1.18
+56.46%
-2.71
Basic EPS
-0.75
-200.00%
-0.25
+78.81%
-1.18
+56.46%
-2.71
Basic Average Shares
228.52
+1.01%
226.23
+48.23%
152.62
+80.46%
84.57
Diluted Average Shares
228.52
+1.01%
226.23
+48.23%
152.62
+80.46%
84.57
Diluted NI Availto Com Stockholders
-170.37
-201.39%
-56.53
+68.56%
-179.82
+21.61%
-229.38
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
172.25
-45.37%
315.29
+1.08%
311.92
+14.49%
272.45
Current Assets
167.64
-45.90%
309.89
+1.10%
306.52
+17.05%
261.88
Cash Cash Equivalents And Short Term Investments
136.93
-53.51%
294.52
-0.64%
296.43
+15.94%
255.68
Cash And Cash Equivalents
37.73
-18.11%
46.07
+43.49%
32.11
-71.32%
111.97
Other Short Term Investments
99.20
-60.07%
248.44
-6.00%
264.32
+83.93%
143.71
Receivables
12.23
+129.06%
5.34
0.00
—
Other Receivables
12.23
+129.06%
5.34
—
—
Prepaid Assets
—
—
—
6.20
Restricted Cash
—
—
—
0.00
Other Current Assets
18.48
+84.26%
10.03
-0.61%
10.09
+62.75%
6.20
Total Non Current Assets
4.61
-14.79%
5.40
+0.13%
5.40
-48.94%
10.57
Net PPE
4.20
-18.04%
5.12
+7.16%
4.78
-51.68%
9.89
Gross PPE
4.40
-16.97%
5.30
-48.06%
10.21
-36.19%
16.00
Accumulated Depreciation
-0.21
-13.11%
-0.18
+96.63%
-5.43
+11.13%
-6.11
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
—
0.00
-100.00%
1.27
-5.78%
1.35
Construction In Progress
—
—
0.00
-100.00%
0.08
Other Properties
4.33
-18.44%
5.30
-16.83%
6.38
-46.89%
12.01
Leases
0.08
0.00
-100.00%
2.56
+0.00%
2.56
Other Non Current Assets
0.41
+44.17%
0.28
-54.21%
0.62
-9.12%
0.68
Total Liabilities Net Minority Interest
295.01
+3.22%
285.80
+14.71%
249.15
-4.31%
260.37
Current Liabilities
63.44
+40.94%
45.01
-12.77%
51.60
+4.81%
49.23
Payables And Accrued Expenses
31.30
+108.60%
15.00
-43.14%
26.39
+25.07%
21.10
Payables
5.96
+157.22%
2.32
-58.03%
5.53
+278.75%
1.46
Accounts Payable
5.96
+156.96%
2.32
-58.03%
5.53
+278.75%
1.46
Current Accrued Expenses
25.33
+99.72%
12.69
-39.20%
20.86
+6.22%
19.64
Pensionand Other Post Retirement Benefit Plans Current
11.21
-6.54%
11.99
+16.52%
10.29
-23.94%
13.53
Total Tax Payable
0.01
0.00
—
—
Income Tax Payable
0.01
0.00
—
—
Current Debt And Capital Lease Obligation
0.94
-2.39%
0.96
-93.56%
14.91
+2.19%
14.60
Current Debt
—
—
11.61
+0.00%
11.61
Other Current Borrowings
—
—
11.61
+0.00%
11.61
Current Capital Lease Obligation
0.94
-2.39%
0.96
-70.90%
3.30
+10.69%
2.98
Current Deferred Liabilities
19.99
+17.23%
17.05
0.00
—
Current Deferred Revenue
19.99
+17.23%
17.05
0.00
—
Total Non Current Liabilities Net Minority Interest
231.57
-3.83%
240.79
+21.89%
197.55
-6.44%
211.14
Long Term Debt And Capital Lease Obligation
201.97
+0.02%
201.92
+2.21%
197.55
-6.44%
211.14
Long Term Debt
198.51
+0.50%
197.52
+0.06%
197.41
-4.96%
207.70
Long Term Capital Lease Obligation
3.46
-21.33%
4.40
+2954.17%
0.14
-95.82%
3.45
Non Current Deferred Liabilities
29.61
-23.83%
38.87
0.00
—
Non Current Deferred Revenue
29.61
-23.83%
38.87
0.00
—
Stockholders Equity
-122.76
-516.25%
29.49
-53.02%
62.77
+419.74%
12.08
Common Stock Equity
-122.76
-516.25%
29.49
-53.02%
62.77
+419.74%
12.08
Capital Stock
0.02
+4.35%
0.02
+0.00%
0.02
+130.00%
0.01
Common Stock
0.02
+4.35%
0.02
+0.00%
0.02
+130.00%
0.01
Share Issued
233.68
+3.12%
226.60
+0.53%
225.41
+138.72%
94.42
Ordinary Shares Number
233.68
+3.12%
226.60
+0.53%
225.41
+138.72%
94.42
Additional Paid In Capital
1,321.30
+1.89%
1,296.85
+1.70%
1,275.14
+22.04%
1,044.86
Retained Earnings
-1,438.94
-13.43%
-1,268.57
-4.66%
-1,212.04
-17.42%
-1,032.22
Gains Losses Not Affecting Retained Earnings
-5.15
-533.05%
1.19
+439.71%
-0.35
+39.02%
-0.57
Other Equity Adjustments
-5.15
-533.05%
1.19
+439.71%
-0.35
+39.02%
-0.57
Total Equity Gross Minority Interest
-122.76
-516.25%
29.49
-53.02%
62.77
+419.74%
12.08
Total Capitalization
75.75
-66.63%
227.01
-12.74%
260.17
+18.38%
219.77
Working Capital
104.21
-60.66%
264.88
+3.91%
254.92
+19.88%
212.65
Invested Capital
75.75
-66.63%
227.01
-16.47%
271.79
+17.46%
231.39
Total Debt
202.91
+0.01%
202.88
-4.51%
212.46
-5.88%
225.74
Net Debt
160.78
+6.16%
151.45
-14.39%
176.91
+64.82%
107.34
Capital Lease Obligations
4.40
-17.93%
5.36
+55.51%
3.45
-46.40%
6.43
Net Tangible Assets
-122.76
-516.25%
29.49
-53.02%
62.77
+419.74%
12.08
Tangible Book Value
-122.76
-516.25%
29.49
-53.02%
62.77
+419.74%
12.08
Interest Payable
0.83
+0.00%
0.83
-13.95%
0.97
-9.11%
1.06
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-171.27
-4838.47%
-3.47
+97.82%
-159.16
+14.90%
-187.03
Cash Flow From Continuing Operating Activities
-171.27
-4838.47%
-3.47
+97.82%
-159.16
+14.90%
-187.03
Net Income From Continuing Operations
-170.37
-201.39%
-56.53
+68.56%
-179.82
+21.61%
-229.38
Depreciation Amortization Depletion
1.00
-75.86%
4.15
-5.34%
4.38
-0.99%
4.43
Depreciation
1.00
-75.86%
4.15
-5.34%
4.38
-0.99%
4.43
Depreciation And Amortization
1.00
-75.86%
4.15
-5.34%
4.38
-0.99%
4.43
Other Non Cash Items
8.46
+679.01%
1.09
-90.41%
11.32
+821.91%
1.23
Stock Based Compensation
10.55
-48.81%
20.62
-27.70%
28.52
-32.98%
42.55
Operating Gains Losses
-0.01
-100.62%
0.81
+11.02%
0.73
—
Gain Loss On Investment Securities
-0.01
—
—
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.81
+11.02%
0.73
0.00
Change In Working Capital
-13.63
-134.54%
39.46
+365.89%
-14.84
-232.83%
-4.46
Change In Receivables
-6.89
-29.06%
-5.34
0.00
0.00
Change In Prepaid Assets
-8.45
-13733.87%
0.06
+101.59%
-3.89
-1414.86%
0.30
Change In Payables And Accrued Expense
9.12
+212.20%
-8.13
-1.28%
-8.03
-229.87%
-2.43
Change In Accrued Expense
11.87
+283.31%
-6.48
+46.12%
-12.02
-1835.43%
-0.62
Change In Payable
-2.75
-65.88%
-1.66
-141.50%
3.99
+320.08%
-1.81
Change In Account Payable
-2.75
-65.88%
-1.66
-141.50%
3.99
+320.08%
-1.81
Change In Other Working Capital
-6.33
-111.31%
55.92
—
1.62
Change In Other Current Assets
-0.12
-137.31%
0.34
+440.32%
0.06
-84.50%
0.40
Change In Other Current Liabilities
-0.96
+71.62%
-3.39
-13.55%
-2.98
-9.59%
-2.72
Investing Cash Flow
156.36
+438.74%
29.02
+126.15%
-110.97
-10621.74%
-1.03
Cash Flow From Continuing Investing Activities
156.36
+438.74%
29.02
+126.15%
-110.97
-10621.74%
-1.03
Net PPE Purchase And Sale
-0.08
0.00
0.00
+100.00%
-0.41
Purchase Of PPE
-0.08
0.00
0.00
+100.00%
-0.41
Capital Expenditure
-0.08
—
—
-0.47
Net Investment Purchase And Sale
156.44
+439.01%
29.02
+126.15%
-110.97
-19716.07%
-0.56
Purchase Of Investment
-227.11
+54.10%
-494.78
-12.02%
-441.67
-85.53%
-238.06
Sale Of Investment
383.54
-26.78%
523.80
+58.39%
330.70
+39.24%
237.50
Net Intangibles Purchase And Sale
—
0.00
0.00
+100.00%
-0.07
Purchase Of Intangibles
—
0.00
0.00
+100.00%
-0.07
Financing Cash Flow
6.42
+155.93%
-11.49
-106.04%
190.15
+62.40%
117.09
Cash Flow From Continuing Financing Activities
6.42
+155.93%
-11.49
-106.04%
190.15
+62.40%
117.09
Net Issuance Payments Of Debt
0.00
+100.00%
-12.58
-8.34%
-11.61
-100.02%
-5.81
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
0.00
+100.00%
-12.58
-8.34%
-11.61
-100.02%
-5.81
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
0.00
+100.00%
-12.58
-8.34%
-11.61
-100.02%
-5.81
Net Long Term Debt Issuance
0.00
+100.00%
-12.58
-8.34%
-11.61
-100.02%
-5.81
Net Common Stock Issuance
0.00
0.00
-100.00%
201.32
+67.84%
119.95
Proceeds From Stock Option Exercised
6.42
+487.83%
1.09
+146.17%
0.44
-84.95%
2.95
Changes In Cash
-8.48
-160.30%
14.07
+117.59%
-79.97
-12.68%
-70.98
Effect Of Exchange Rate Changes
0.14
+238.24%
-0.10
-192.73%
0.11
+121.28%
-0.52
Beginning Cash Position
46.07
+43.49%
32.11
-71.32%
111.97
-38.97%
183.47
End Cash Position
37.73
-18.11%
46.07
+43.49%
32.11
-71.32%
111.97
Free Cash Flow
-171.34
-4840.74%
-3.47
+97.82%
-159.16
+15.12%
-187.51
Interest Paid Supplemental Data
10.00
-5.31%
10.56
-14.05%
12.29
-3.34%
12.71
Amortization Of Securities
-7.28
+44.28%
-13.06
-38.22%
-9.45
-572.60%
-1.41
Change In Interest Payable
0.00
+100.00%
-0.14
-39.18%
-0.10
-9600.00%
-0.00
Common Stock Issuance
0.00
0.00
-100.00%
201.32
+67.84%
119.95
Issuance Of Capital Stock
0.00
0.00
-100.00%
201.32
+67.84%
119.95
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category